CONSENT AND WAIVERConsent and Waiver • February 25th, 2021 • Cure Pharmaceutical Holding Corp. • Pharmaceutical preparations
Contract Type FiledFebruary 25th, 2021 Company IndustryThis CONSENT AND WAIVER (this “Waiver”), dated as of February 25, 2021, is entered into by and between CURE Pharmaceutical Holding Corp., a Delaware corporation with offices located at 1620 Beacon Place, Oxnard, California 93033 (the “Company”), and Ionic Ventures, LLC, a California limited liability company with offices located at 3053 Fillmore Street, Suite 256, San Francisco, CA 94123 (the “Investor”).